Lucid Diagnostics Inc.
LUCD
$1.01
$0.021.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 51.69% | 25.65% | 3.33% | 19.16% | -17.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.69% | 25.65% | 3.33% | 19.16% | -17.28% |
| Cost of Revenue | 4.77% | -13.29% | 0.77% | -3.16% | -6.34% |
| Gross Profit | 48.96% | 62.45% | 5.08% | 37.30% | -10.38% |
| SG&A Expenses | 1.98% | 19.85% | 5.15% | 6.03% | 23.80% |
| Depreciation & Amortization | 0.00% | -0.94% | 0.00% | 0.00% | -32.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.41% | 14.32% | 0.81% | 3.11% | 12.91% |
| Operating Income | 2.99% | -13.22% | -0.56% | -1.72% | -15.71% |
| Income Before Tax | 48.31% | -40.94% | 15.96% | 59.66% | -153.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 48.31% | -40.94% | 15.96% | 59.66% | -153.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.31% | -40.94% | 15.96% | 59.66% | -153.56% |
| EBIT | 2.99% | -13.22% | -0.56% | -1.72% | -15.71% |
| EBITDA | 3.05% | -13.57% | -0.52% | -1.82% | -19.19% |
| EPS Basic | 67.77% | 37.38% | 60.87% | 65.09% | -30.13% |
| Normalized Basic EPS | 52.35% | 49.81% | 53.23% | 50.49% | 24.28% |
| EPS Diluted | 67.77% | 37.38% | 60.87% | 65.09% | -30.13% |
| Normalized Diluted EPS | 52.35% | 49.81% | 53.23% | 50.49% | 24.28% |
| Average Basic Shares Outstanding | 103.64% | 125.07% | 114.75% | 105.32% | 52.83% |
| Average Diluted Shares Outstanding | 103.64% | 125.07% | 114.75% | 105.32% | 52.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |